Benzoic Acid

Benzoic Acid

SCHEMBL64441

CCNCC.O=C(O)c1ccccc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.64
DAO P14920 1/20 0.64
NAPRT Q6XQN6 1/20 0.64
CES1 P23141 5/20 0.54
CES2 O00748 4/20 0.54
SRD5A2 P31213 1/20 0.54
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 1/20 0.48
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terephthalic Acid SCHEMBL27842309 0.91 ALDH1A1 (0.60) TSHRDAONAPRTSRD5A2ALDH1A1
Terephthalic Acid SCHEMBL31728724 0.91 ALDH1A1 (0.60) TSHRDAONAPRTSRD5A2ALDH1A1
Isophthalic Acid SCHEMBL459728 0.87 CA12 (0.52) ALDH1A1MEN1KMT2AKDM4EMAPT
Benzil SCHEMBL28793382 0.86 CES2 (0.64) TSHRCES1CES2ALDH1A1MEN1
Benzoic Acid SCHEMBL1886522 0.86 TSHR (0.64) TSHRDAONAPRTCES1CES2
Benzophenone SCHEMBL5804441 0.86 ALDH1A1 (0.64) CES1CES2SRD5A2ALDH1A1MEN1
Benzophenone SCHEMBL27800808 0.86 ALDH1A1 (0.64) CES1CES2SRD5A2ALDH1A1MEN1
Benzophenone SCHEMBL490746 0.86 ALDH1A1 (0.64) CES1CES2SRD5A2ALDH1A1MEN1
Benzoic Acid SCHEMBL2400344 0.85 TSHR (0.78) TSHRDAONAPRTCES1CES2
Benzoic Acid SCHEMBL28693411 0.85 TSHR (0.78) TSHRDAONAPRTCES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0680078-B1 Semiconductor substrate surface treatment MITSUBISHI GAS CHEMICAL CO (JP) 2003-03-12 EP claimed
US-5972862-A COMPRISING A FLUORINE-CONTAINING COMPOUND, A WATER-SOLUBLE OR WATER-MISCIBLE ORGANIC SOLVENT, AN ORGANIC ACID, AND A QUATERNARY AMMONIUM SALT MITSUBISHI GAS CHEMICAL (JP) 1999-10-26 US claimed
US-5630904-A Stripping and cleaning agent for removing dry-etching and photoresist residues from a semiconductor substrate, and a method for forming a line pattern using the stripping and cleaning agent MITSUBISHI GAS CHEMICAL CO., INC. (JP) 1997-05-20 US claimed
US-5466858-A Ruthenium catalyst, high selectivity with a carboxylic acid UBE INDUSTRIES, LTD. (JP) 1995-11-14 US claimed
EP-0680078-A2 Semiconductor substrate surface treatment MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-11-02 EP claimed
US-4479889-A TREATING TO MAKE INEDIBLE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1984-10-30 US claimed
US-12564543-B2 Dental composition KURARAY NORITAKE DENTAL INC. (JP) 2026-03-03 US disclosed
EP-3416176-B1 ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION SANYO CHEMICAL IND LTD (JP) 2026-01-07 EP disclosed
US-12173149-B2 Composite particles, kit, material, and method for producing composite particles SUN MEDICAL CO., LTD. (JP) 2024-12-24 US disclosed
US-12146010-B2 Amine co-initiator mixture ARKEMA FRANCE (FR) 2024-11-19 US disclosed
US-20240141078-A1 AMINE CO-INITIATOR MIXTURE ARKEMA FRANCE (FR) 2024-05-02 US disclosed
EP-3835329-B1 POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION MITSUI CHEMICALS INC (JP) 2024-05-01 EP disclosed
US-20240091107-A1 DENTAL COMPOSITION KURARAY NORITAKE DENTAL INC. (JP) 2024-03-21 US disclosed
US-4760183-A Process for the preparation of aromatic dialkylamines HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-26 US disclosed
US-4715976-A QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-12-29 US disclosed
EP-0246825-A2 Quaternary salt solution electrolyte for electrolytic capacitors MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-11-25 EP disclosed
EP-0227433-A2 Electrolyte solution of quaternary ammonium salt for electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-07-01 EP disclosed
EP-0223245-A2 Curable compositions for dental drugs having sustained release property MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1987-05-27 EP disclosed
US-4479889-A TREATING TO MAKE INEDIBLE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1984-10-30 US disclosed
US-4247458-A COUPLING DIAZONIUM SALT WITH DISPERSE DYE COUPLER WITH DISPLACEABLE GROUP OTHER THAN HYDROGEN EASTMAN KODAK COMPANY (US) 1981-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12146010-B2 Amine co-initiator mixture JMJD6, KDM2B, KDM1B TSHR 4410/4885DAO 239/4885NAPRT 2211/4885
US-20240091107-A1 DENTAL COMPOSITION CCT7, TAS2R42, CCT5 TSHR 3718/4885DAO 2526/4885NAPRT 4561/4885
US-20240141078-A1 AMINE CO-INITIATOR MIXTURE JMJD6, KDM2B, KDM1B TSHR 4410/4885DAO 239/4885NAPRT 2211/4885
US-12564543-B2 Dental composition CAD, ARCN1, MAT1A TSHR 4074/4885DAO 583/4885NAPRT 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.